News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
359,440 Results
Type
Article (22293)
Company Profile (33)
Press Release (337114)
Multimedia
Podcasts (74)
Webinars (5)
Section
Business (118256)
Career Advice (1400)
Deals (17177)
Drug Delivery (53)
Drug Development (41767)
Employer Resources (94)
FDA (8605)
Job Trends (8307)
News (188456)
Policy (16894)
Tag
2024 BioCapital Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1438)
Academic (1)
Accelerated approval (4)
Adcomms (10)
Allergies (46)
Alliances (32913)
ALS (54)
Alzheimer's disease (793)
Antibody-drug conjugate (ADC) (61)
Approvals (8637)
Artificial intelligence (152)
Autoimmune disease (13)
Automation (12)
Bankruptcy (156)
Best Places to Work (6962)
BIOSECURE Act (5)
Biosimilars (49)
Biotechnology (25)
Bladder cancer (42)
Brain cancer (11)
Breast cancer (169)
Cancer (1313)
Cardiovascular disease (108)
Career advice (1188)
Career pathing (22)
CAR-T (75)
Cell therapy (254)
Cervical cancer (13)
Clinical research (33915)
Collaboration (581)
Compensation (111)
Complete response letters (8)
COVID-19 (1410)
CRISPR (24)
C-suite (108)
Cystic fibrosis (52)
Data (1386)
Decentralized trials (2)
Denatured (24)
Depression (21)
Diabetes (175)
Diagnostics (3349)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (29)
Drug discovery (72)
Drug pricing (53)
Drug shortages (18)
Duchenne muscular dystrophy (63)
Earnings (54689)
Editorial (28)
Employer branding (12)
Employer resources (82)
Events (53848)
Executive appointments (370)
FDA (9306)
Featured Employer (16)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (390)
Gene editing (57)
Generative AI (17)
Gene therapy (197)
GLP-1 (408)
Government (2216)
Grass and pollen (3)
Guidances (39)
Healthcare (10134)
Huntington's disease (11)
IgA nephropathy (14)
Immunology and inflammation (68)
Indications (20)
Infectious disease (1482)
Inflammatory bowel disease (86)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (60)
Interviews (260)
IPO (8269)
IRA (26)
Job creations (1697)
Job search strategy (989)
Kidney cancer (3)
Labor market (19)
Layoffs (209)
Leadership (14)
Legal (4348)
Liver cancer (33)
Lung cancer (197)
Lymphoma (89)
Machine learning (1)
Management (32)
Manufacturing (165)
MASH (44)
Medical device (6557)
Medtech (6561)
Mergers & acquisitions (9252)
Metabolic disorders (420)
Multiple sclerosis (50)
NASH (9)
Neurodegenerative disease (46)
Neuropsychiatric disorders (12)
Neuroscience (1082)
NextGen: Class of 2025 (3365)
Non-profit (2657)
Northern California (1422)
Now hiring (4)
Obesity (212)
Opinion (150)
Ovarian cancer (41)
Pain (48)
Pancreatic cancer (46)
Parkinson's disease (79)
Partnered (12)
Patents (132)
Patient recruitment (53)
Peanut (23)
People (26994)
Pharmaceutical (11)
Pharmacy benefit managers (8)
Phase I (10126)
Phase II (14391)
Phase III (12132)
Pipeline (875)
Policy (77)
Postmarket research (1631)
Preclinical (4446)
Press Release (31)
Prostate cancer (82)
Psychedelics (18)
Radiopharmaceuticals (144)
Rare diseases (222)
Real estate (2517)
Recruiting (36)
Regulatory (11472)
Reports (16)
Research institute (1314)
Resumes & cover letters (214)
Rett syndrome (1)
RNA editing (2)
RSV (22)
Schizophrenia (40)
Series A (70)
Series B (41)
Service/supplier (3)
Sickle cell disease (35)
Southern California (1246)
Special edition (7)
Spinal muscular atrophy (68)
Sponsored (17)
Startups (1471)
State (1)
Stomach cancer (9)
Supply chain (27)
Tariffs (11)
The Weekly (49)
United States (12723)
Vaccines (379)
Venture capitalists (17)
Weight loss (133)
Women's health (17)
Worklife (11)
Date
Today (70)
Last 7 days (268)
Last 30 days (1534)
Last 365 days (19308)
2025 (5575)
2024 (20142)
2023 (22145)
2022 (27996)
2021 (29791)
2020 (29081)
2019 (24989)
2018 (18476)
2017 (17409)
2016 (16946)
2015 (19291)
2014 (16211)
2013 (14179)
2012 (13984)
2011 (13417)
2010 (12661)
Location
Africa (530)
Alabama (38)
Alaska (4)
Arizona (85)
Arkansas (7)
Asia (20852)
Australia (3427)
California (3218)
Canada (1141)
China (285)
Colorado (163)
Connecticut (174)
Delaware (83)
Europe (49184)
Florida (575)
Georgia (132)
Idaho (20)
Illinois (277)
India (19)
Indiana (193)
Iowa (3)
Japan (97)
Kansas (55)
Kentucky (8)
Louisiana (4)
Maine (27)
Maryland (461)
Massachusetts (2487)
Michigan (121)
Minnesota (171)
Missouri (30)
Montana (8)
Nebraska (9)
Nevada (29)
New Hampshire (28)
New Jersey (1106)
New Mexico (12)
New York (983)
North Carolina (592)
North Dakota (3)
Northern California (1422)
Ohio (101)
Oklahoma (11)
Oregon (18)
Pennsylvania (768)
Puerto Rico (1)
Rhode Island (19)
South America (740)
South Carolina (12)
Southern California (1246)
Tennessee (63)
Texas (473)
Utah (110)
Virginia (72)
Washington D.C. (38)
Washington State (307)
West Virginia (2)
Wisconsin (26)
359,440 Results for "bausch and lomb".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
March 27, 2025
·
1 min read
Press Releases
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States
March 17, 2025
·
6 min read
Press Releases
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
January 13, 2025
·
4 min read
Press Releases
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
February 19, 2025
·
19 min read
Press Releases
InflammX Therapeutics Announces Option Agreement with Bausch + Lomb
January 10, 2025
·
2 min read
Press Releases
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
December 12, 2024
·
3 min read
Press Releases
Bausch + Lomb Responds to Rumors of a Potential Sale
December 12, 2024
·
3 min read
Press Releases
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
January 10, 2025
·
2 min read
Press Releases
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
January 22, 2025
·
1 min read
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced the U.S. introduction of Bausch + Lomb INFUSE for Astigmatism daily disposable contact lenses.
June 10, 2024
·
6 min read
1 of 35,944
Next
